Alberto Gil-Jimenez
6PUBLICATIONS
46CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 09, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.Chantal F Stockem, Alberto Gil-Jimenez, Hamza Ali
|Jul 24, 2024
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment.Maksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe
|Mar 22, 2024
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors.Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos
|Feb 14, 2024
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.Maud Rijnders, J Alberto Nakauma-González, Debbie G J Robbrecht
|Jul 24, 2023
Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.Hielke M de Vries, Tynisha S Rafael, Alberto Gil-Jimenez
|Oct 13, 2020
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.Nick van Dijk, Alberto Gil-Jimenez, Karina Silina
Pageof 1
Frequent Collaborators
6 joint publications
Michiel S van der Heijden
5 joint publications
Erik Hooijberg
4 joint publications
Lodewyk F A Wessels
3 joint publications
Niven Mehra
3 joint publications
Bas W G van Rhijn
3 joint publications
Dennis Peters
3 joint publications
Annegien Broeks
2 joint publications
Jeroen van Dorp
2 joint publications
Maartje Alkemade
2 joint publications
Iris M Seignette
